← Eichor
Study identifier: NCT06590623 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effect of Acute Exogenous Oral Ketone Supplementation on Immune Cells Function and Immune Cells Histone Β-hydroxybutyrylation

Condition: Ketosis, Metabolic · Immune Functions · Histone Deacetylase (HDAC) Activity  ·  Sponsor: University of British Columbia

PhaseNA
Planned participants12
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersYes

About this study

To conduct a single-arm pilot study to determine how acute ingestion of an exogenous ketone monoester supplement alters the histone lysine β-hydroxybutyrylation and immune function in healthy human monocytes and lymphocytes.

This description comes directly from the study's public registry record.

Talk to the study team

Jonathan Little Principal Investigator, Professor Little, Ph.D  ·  250-807-9876  ·  jonathan.little@ubc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

University of British Columbia Okanagan CampusKelowna, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06590623